Eng‐king Tan
#143,066
Most Influential Person Now
Eng‐king Tan's AcademicInfluence.com Rankings
Eng‐king Tanphilosophy Degrees
Philosophy
#7561
World Rank
#10794
Historical Rank
Logic
#4612
World Rank
#5926
Historical Rank
Eng‐king Tanbiology Degrees
Biology
#10230
World Rank
#13538
Historical Rank
Neuroscience
#1569
World Rank
#1620
Historical Rank
Download Badge
Philosophy Biology
Eng‐king Tan's Degrees
- PhD Neuroscience University of California, San Francisco
- Doctorate Medicine Stanford University
Why Is Eng‐king Tan Influential?
(Suggest an Edit or Addition)Eng‐king Tan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. (2009) (965)
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) (811)
- Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons. (2016) (523)
- Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. (2006) (505)
- Restless legs syndrome in an Asian population: A study in Singapore (2001) (279)
- Pathogenic mutations in Parkinson disease (2007) (251)
- Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila (2009) (213)
- Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease (2008) (191)
- Parkinson disease and the immune system — associations, mechanisms and therapeutics (2020) (182)
- Case control study of diffusion tensor imaging in Parkinson’s disease (2007) (174)
- The LRRK2 Gly2385Arg variant is associated with Parkinson’s disease: genetic and functional evidence (2006) (170)
- Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. (2007) (170)
- Evaluation of somnolence in Parkinson’s disease: Comparison with age- and sex-matched controls (2002) (168)
- The impact of non‐motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study (2016) (163)
- Meta-analysis of the association between variants in SORL1 and Alzheimer disease. (2011) (159)
- A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson’s disease models (2014) (156)
- The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients (2005) (151)
- AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease (2012) (148)
- Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease (2008) (137)
- Large-scale replication and heterogeneity in Parkinson disease genetic loci (2012) (133)
- Deletion of the WD40 Domain of LRRK2 in Zebrafish Causes Parkinsonism-Like Loss of Neurons and Locomotive Defect (2010) (131)
- Evidence of Inflammatory System Involvement in Parkinson's Disease (2014) (127)
- Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies (2016) (127)
- The roles of amyloid precursor protein (APP) in neurogenesis (2011) (123)
- Historical Perspective: Models of Parkinson’s Disease (2020) (123)
- Case Control Polysomnographic Studies of Sleep Disorders in Parkinson's Disease (2011) (120)
- Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3. (2016) (119)
- Multiple LRRK2 variants modulate risk of Parkinson disease: a chinese multicenter study (2010) (115)
- Whole-genome and whole-exome sequencing in neurological diseases (2012) (114)
- Role of MicroRNAs in Parkinson’s Disease (2019) (109)
- Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress‐induced neuronal death (2011) (108)
- Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study. (2020) (108)
- PINK1 mutations in sporadic early‐onset Parkinson's disease (2006) (107)
- A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants (2012) (105)
- Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases (2017) (99)
- Restless legs syndrome in Parkinson's disease (2002) (96)
- MDR1, the blood–brain barrier transporter, is associated with Parkinson’s disease in ethnic Chinese (2004) (95)
- Genome-wide association study of Parkinson’s disease in East Asians (2016) (94)
- Case–control study of restless legs syndrome and quality of sleep in Parkinson's disease (2008) (93)
- Potassium channel dysfunction in human neuronal models of Angelman syndrome (2019) (92)
- A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease (2013) (92)
- Alpha-synuclein haplotypes implicated in risk of Parkinson’s disease (2004) (92)
- Sleep and Parkinson's disease: A review of case‐control polysomnography studies (2012) (92)
- Parkinson's disease in the Western Pacific Region (2019) (90)
- Large-Scale Whole-Genome Sequencing of Three Diverse Asian Populations in Singapore (2018) (89)
- Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore (2008) (88)
- The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications (2008) (84)
- Effect of MDR1 haplotype on risk of Parkinson disease. (2005) (82)
- Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. (2005) (81)
- Evidence of increased odds of essential tremor in Parkinson's disease (2008) (81)
- Alpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients (2005) (79)
- Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30) (2004) (78)
- microRNAs and Neurodegenerative Diseases. (2015) (78)
- MDS evidence‐based review of treatments for essential tremor (2019) (77)
- SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese (2009) (77)
- A rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease (2013) (76)
- Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria (2017) (76)
- Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice (2016) (76)
- A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease (2011) (74)
- Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability (2003) (73)
- Analysis of LRRK2 functional domains in nondominant Parkinson disease (2005) (73)
- Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients. (2007) (71)
- Valproate‐induced Parkinsonism in epilepsy patients (2007) (69)
- Genetic variants in sporadic Parkinson's disease: East vs West. (2012) (68)
- The role of IgA in COVID-19 (2020) (68)
- Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort (2004) (67)
- CARD15 variants in patients with sporadic Parkinson's disease (2007) (67)
- LINGO1 VARIANT INCREASES RISK OF FAMILIAL ESSENTIAL TREMOR (2009) (66)
- Analysis of MDR1 haplotypes in Parkinson's disease in a white population (2004) (64)
- LRRK2 R1628P increases risk of Parkinson’s disease: replication evidence (2008) (63)
- F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy. (2015) (62)
- Non-motor manifestations in essential tremor: use of a validated instrument to evaluate a wide spectrum of symptoms. (2005) (62)
- Flow Cytometry-Based Assessment of Mitophagy Using MitoTracker (2016) (59)
- Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late‐onset Parkinson's disease (2006) (59)
- Spinocerebellar ataxia type 3 presenting as an l-DOPA responsive dystonia phenotype in a Chinese family (2003) (58)
- Essential tremor-plus: a controversial new concept (2019) (58)
- The role of common genetic risk variants in Parkinson disease (2007) (57)
- Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease (2014) (57)
- Transducer‐based evaluation of tremor (2016) (56)
- MiRNA-128 regulates the proliferation and neurogenesis of neural precursors by targeting PCM1 in the developing cortex (2016) (56)
- The role of gut dysbiosis in Parkinson's disease: mechanistic insights andtherapeutic options. (2021) (56)
- Association of GWAS loci with PD in China (2011) (55)
- Non‐motor symptoms in early Parkinson's disease with different motor subtypes and their associations with quality of life (2018) (55)
- Validation of a short disease specific quality of life scale for hemifacial spasm: correlation with SF-36 (2005) (52)
- A case-controlled MRI/MRA study of neurovascular contact in hemifacial spasm. (2000) (52)
- Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers (2007) (50)
- Non-Motor and Motor Features in LRRK2 Transgenic Mice (2013) (50)
- Behind the facial twitch: depressive symptoms in hemifacial spasm. (2005) (50)
- Lingo2 variants associated with essential tremor and Parkinson’s disease (2011) (50)
- Restless legs symptoms in thyroid disorders. (2004) (49)
- Notch as a molecular switch in neural stem cells (2010) (49)
- Genetic testing in spinocerebellar ataxias: defining a clinical role. (2001) (48)
- Amyloid-β and Parkinson’s disease (2018) (47)
- Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges (2016) (46)
- Association of NOTCH2NLC Repeat Expansions With Parkinson Disease. (2020) (46)
- Alpha‐synuclein mRNA expression in sporadic Parkinson's disease (2005) (46)
- Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance (2020) (45)
- Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson's disease: PALS study. (2018) (42)
- Identification of a common genetic risk variant (LRRK2 Gly2385Arg) in Parkinson's disease. (2006) (42)
- Intermediate C9orf72 alleles in neurological disorders: does size really matter? (2017) (42)
- Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease (2005) (42)
- CHCHD2 and Parkinson's disease (2015) (42)
- Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease. (2014) (41)
- Transcallosal diffusion tensor abnormalities in predominant gait disorder parkinsonism. (2014) (41)
- Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila. (2014) (40)
- Role of magnetic resonance imaging and magnetic resonance angiography in patients with hemifacial spasm. (1999) (40)
- Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson’s disease (2017) (40)
- Molecular biology changes associated with LRRK2 mutations in Parkinson's disease (2008) (40)
- Targeting LRRK2 in Parkinson’s disease: an update on recent developments (2017) (39)
- Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population (2007) (39)
- From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease (2013) (39)
- Genetic analysis of Nurr1 haplotypes in Parkinson's disease (2003) (39)
- COQ2 gene variants associate with cerebellar subtype of multiple system atrophy in Chinese (2015) (39)
- Prospective longitudinal study of frailty transitions in a community-dwelling cohort of older adults with cognitive impairment (2015) (38)
- In vivo evidence of pathogenicity of VPS35 mutations in the Drosophila (2014) (38)
- Coexistent blepharospasm and hemifacial spasm: overlapping pathophysiologic mechanism? (2004) (38)
- PLA2G6 mutations and Parkinson's disease (2010) (37)
- Collaborative Analysis of (cid:1) -Synuclein Gene Promoter Variability and Parkinson Disease (2006) (37)
- SLC1A2 variant associated with essential tremor but not Parkinson disease in Chinese subjects (2013) (36)
- Analysis of Lingo1 variant in sporadic and familial essential tremor among Asians (2011) (36)
- White matter microstructural characteristics in newly diagnosed Parkinson’s disease: An unbiased whole-brain study (2016) (36)
- Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: implications for iron-related dopaminergic neuron degeneration. (2010) (36)
- Messaging Fatigue and Desensitisation to Information During Pandemic (2020) (36)
- Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson's disease: A resting state functional MRI study. (2016) (36)
- Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease (2005) (36)
- Haplotype analysis of the ETM2 locus in familial essential tremor (2003) (35)
- Differential White Matter Regional Alterations in Motor Subtypes of Early Drug-Naive Parkinson’s Disease Patients (2018) (34)
- Ipsilateral Stroke in a Patient With Horizontal Gaze Palsy With Progressive Scoliosis and a Subcortical Infarct (2011) (33)
- Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations (2006) (33)
- Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson’s disease (PD) (2016) (33)
- Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson’s Disease (2015) (33)
- Identification of a novel risk variant in the FUS gene in essential tremor (2013) (33)
- Analysis of LRRK2 Gly2385Arg genetic variant in non‐Chinese Asians (2007) (32)
- Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study (2015) (32)
- Severe bruxism following basal ganglia infarcts: insights into pathophysiology (2004) (32)
- Ring finger protein 146/Iduna is a Poly(ADP-ribose) polymer binding and PARsylation dependent E3 ubiquitin ligase (2011) (32)
- Immature Midbrain Dopaminergic Neurons Derived from Floor‐Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease (2017) (32)
- Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases (2016) (31)
- LRRK2 variant associated with Alzheimer's disease (2011) (31)
- Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence (2012) (31)
- Case–control study of UCHL1 S18Y variant in Parkinson's disease (2006) (31)
- Reversible parkinsonism in systemic lupus erythematosus (2001) (31)
- Antioxidants inhibit neuronal toxicity in Parkinson's disease‐linked LRRK2 (2016) (31)
- Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association (2005) (31)
- Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson’s disease (2020) (31)
- Evolving spectrum of movement disorders in extrapontine and central pontine myelinolysis. (2002) (30)
- NOTCH2NLC GGC repeat expansions are associated with sporadic essential tremor: Variable disease expressivity on long-term follow-up. (2020) (30)
- Genetics of essential tremor. (2016) (30)
- Plasma alpha‐synuclein detected by single molecule array is increased in PD (2019) (30)
- Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson’s disease (2020) (29)
- Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease (2003) (29)
- Genetic analysis of DJ-1 in a cohort Parkinson’s disease patients of different ethnicity (2004) (29)
- LRRK2 G2385R and R1628P Mutations Are Associated with an Increased Risk of Parkinson's Disease in the Malaysian Population (2014) (29)
- Notch as a molecular switch in neural stem cells. (2010) (28)
- Translational potential of human brain organoids (2018) (28)
- Levodopa-induced oromandibular dystonia in progressive supranuclear palsy (2003) (28)
- Restless Legs Syndrome and Parkinson’s Disease: Is there an etiologic link? (2006) (28)
- Sensory tricks and treatment in primary lingual dystonia (2005) (28)
- Non‐replication of association for six polymorphisms from meta‐analysis of genome‐wide association studies of Parkinson's disease: Large‐scale collaborative study (2009) (27)
- Greater motor progression in patients with Parkinson disease who carry LRRK2 risk variants (2015) (27)
- Culture positive tuberculous meningitis: clinical indicators of poor prognosis (1999) (27)
- DNAJ mutations are rare in Chinese Parkinson's disease patients and controls (2014) (27)
- Functional COMT variant predicts response to high dose pyridoxine in Parkinson's disease (2005) (26)
- Absence of A673T amyloid-β precursor protein variant in Alzheimer's disease and other neurological diseases (2013) (26)
- Lrrk2 R1628P in non‐Chinese Asian races (2008) (26)
- Analysis of non-synonymous-coding variants of Parkinson's disease-related pathogenic and susceptibility genes in East Asian populations. (2014) (26)
- Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus (2020) (26)
- Structural connectome alterations in prodromal and de novo Parkinson's disease patients. (2017) (26)
- Pathophysiological mechanisms linking F-box only protein 7 (FBXO7) and Parkinson's disease (PD). (2018) (26)
- Case–control study of anxiety symptoms in hemifacial spasm (2006) (25)
- Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson’s disease (2020) (24)
- Automated analysis of gait and modified timed up and go using the Microsoft Kinect in people with Parkinson’s disease: associations with physical outcome measures (2018) (23)
- Meta-analysis of the Association Between Variants in SORL 1 and Alzheimer Disease (2011) (23)
- An urge to move with L‐thyroxine: Clinical, biochemical, and polysomnographic correlation (2004) (23)
- Polymorphism in semaphorin 5A (Sema5A) gene is not a marker of Parkinson's disease risk (2006) (23)
- Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson’s Disease (2015) (23)
- Large-scale assessment of polyglutamine repeat expansions in Parkinson disease (2015) (23)
- Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity? (2017) (22)
- Clinical characteristics of leg restlessness in Parkinson's disease compared with idiopathic Restless Legs Syndrome (2015) (22)
- Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis (2010) (22)
- Analysis of EIF4G1 in Parkinson's disease among Asians (2013) (22)
- Association of HLA locus variant in Parkinson's disease (2013) (21)
- Whole-exome sequencing in early-onset Parkinson's disease among ethnic Chinese (2020) (21)
- Non-synonymous GIGYF2 variants in Parkinson’s disease from two Asian populations (2009) (21)
- Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson's disease (2020) (20)
- DYT1 mutations amongst adult primary dystonia patients in Singapore with review of literature comparing East and West (2006) (20)
- Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease (2009) (20)
- Nurr1 mutational screen in Parkinson's disease (2004) (20)
- Renin-Angiotensin System Gene Polymorphisms: Its Impact on IgAN and Its Progression to End-Stage Renal Failure among Chinese in Singapore (2004) (20)
- Phenotypic bases of NOTCH2NLC GGC expansion positive neuronal intranuclear inclusion disease in a Southeast Asian cohort (2020) (19)
- Current Opinions and Consensus for Studying Tremor in Animal Models (2019) (19)
- Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants (2017) (19)
- CALHM1 variant is not associated with Alzheimer's disease among Asians (2011) (19)
- Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism (2007) (19)
- Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease (2019) (18)
- “Myorhythmia” slow facial tremor from chronic interferon alpha-2a usage (2003) (18)
- Polymorphism of renin‐angiotensin system genes in IgA nephropathy (2004) (18)
- Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson’s disease (2017) (18)
- Cervical disc prolapse with cord compression presenting with choreoathetosis and dystonia. (2002) (18)
- Essential tremor (2021) (17)
- Analysis of PINK1 in Asian patients with familial parkinsonism (2005) (17)
- “Hot cross bun” is a potential imaging marker for the severity of cerebellar ataxia in MSA-C (2021) (17)
- GRAVES DISEASE AND ISOLATED ORTHOSTATIC TREMOR (2008) (17)
- Lrrk2 R1628P variant is a risk factor for essential tremor (2015) (17)
- Essential tremor and the common LRRK2 G2385R variant. (2008) (17)
- Various Diseases and Clinical Heterogeneity Are Associated With “Hot Cross Bun” (2020) (16)
- Treatment outcome correlates with knowledge of disease in hemifacial spasm (2008) (16)
- LINGO-1 and Neurodegeneration: Pathophysiologic Clues for Essential Tremor (2012) (16)
- GWAS-linked GAK locus in Parkinson’s disease in Han Chinese and meta-analysis (2012) (16)
- LRRK2 interacts with ATM and regulates Mdm2–p53 cell proliferation axis in response to genotoxic stress (2017) (16)
- Validity of family history in essential tremor. (2008) (16)
- Delivering patient-centered care in Parkinson's disease: Challenges and consensus from an international panel. (2020) (16)
- MDPD: an integrated genetic information resource for Parkinson's disease (2008) (16)
- Analysis of LRRK 2 G 2019 S and I 2020 T mutations in Parkinson's disease. (2005) (16)
- Genetic Variations of GAK in Two Chinese Parkinson’s Disease Populations: A Case-Control Study (2013) (16)
- GWAS-linked PPARGC1A variant in Asian patients with essential tremor. (2017) (16)
- In utero infection of Zika virus leads to abnormal central nervous system development in mice (2019) (15)
- Differentiating Parkinson's disease motor subtypes using automated volume‐based morphometry incorporating white matter and deep gray nuclear lesion load (2019) (15)
- X-linked adrenoleukodystrophy: spinocerebellar variant (1999) (15)
- Genetic Association Study betweenSTK39 and CCDC62/HIP1R and Parkinson’s Disease (2013) (15)
- Next-generation sequencing diagnostics for neurological diseases/disorders: from a clinical perspective (2013) (15)
- MAP1B rescues LRRK2 mutant-mediated cytotoxicity (2014) (15)
- Mitochondrial serine protease HTRA2 gene mutation in Asians with coexistent essential tremor and Parkinson disease (2015) (15)
- Essential tremor linked TENM4 mutation found in healthy Chinese individuals. (2016) (15)
- Alpha‐synuclein repeat variants and survival in Parkinson's disease (2014) (15)
- Identification of protein phosphatase 2A as an interacting protein of leucine-rich repeat kinase 2 (2016) (15)
- Movement disorders associated with hyperthyroidism: Expanding the phenotype (2006) (15)
- p62-Mediated mitochondrial clustering attenuates apoptosis induced by mitochondrial depolarization. (2017) (15)
- Expanded FMR1 alleles are rare in idiopathic Parkinson’s disease (2005) (15)
- Targeting leucine-rich repeat kinase 2 in Parkinson's disease (2013) (15)
- Patterns of Linkage Disequilibrium of LRRK2 across Different Races: Implications for Genetic Association Studies (2013) (14)
- SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese (2013) (14)
- Hemidystonia precipitated by acute pontine infarct (2005) (14)
- Ribosomal S6 Kinase 2 (RSK2) Maintains Genomic Stability by Activating the Atm/p53-Dependent DNA Damage Pathway (2013) (14)
- Mental health of scientists in the time of COVID-19 (2020) (14)
- Exploring the relationship between caffeine intake and essential tremor (2006) (14)
- Targeted exome sequencing reveals homozygous TREM2 R47C mutation presenting with behavioral variant frontotemporal dementia without bone involvement (2018) (14)
- Higher serum triglyceride levels are associated with Parkinson's disease mild cognitive impairment (2018) (14)
- SNCA Rep1 promoter variability influences cognition in Parkinson's disease (2019) (14)
- Analysis of the UCHL1 genetic variant in Parkinson's disease among Chinese (2010) (14)
- Modelling Alzheimer's disease: Insights from in vivo to in vitro three‐dimensional culture platforms (2018) (14)
- Genetic analysis of LRRK2 A419V variant in ethnic Chinese (2012) (14)
- New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease (2020) (13)
- Analysis of GWAS-linked variants in multiple system atrophy (2018) (13)
- Etiologic links between environmental and lifestyle factors and Essential tremor (2019) (13)
- Current Status of Stem Cell-Derived Therapies for Parkinson’s Disease: From Cell Assessment and Imaging Modalities to Clinical Trials (2020) (13)
- Dietary Antioxidants and Risk of Parkinson's Disease in the Singapore Chinese Health Study (2020) (13)
- Spinocerebellar Ataxia in Singapore: Predictive Features of a Positive DNA Test? (2000) (13)
- Alcohol dehydrogenase polymorphism and Parkinson's disease (2001) (13)
- Revisiting the link between hypertension and hemifacial spasm (2016) (13)
- Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson’s disease (2015) (13)
- Clinically reported heterozygous mutations in the PINK1 kinase domain exert a gene dosage effect (2009) (13)
- Paroxysmal movement disorders: Recent advances and proposal of a classification system. (2019) (12)
- Acute ataxia, Graves' disease, and stiff person syndrome (2007) (12)
- Analysis of a genome-wide association study-linked locus (CCR6) in Asian rheumatoid arthritis. (2012) (12)
- Comparing LRRK2 Gly2385Arg carriers with noncarriers (2007) (12)
- Erratum to: Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases (2017) (12)
- PARK16 is associated with PD in the Malaysian population (2016) (12)
- Psychogenic tics: diagnostic value of the placebo test. (2004) (12)
- Development of Parkinson’s disease biomarkers (2010) (11)
- A microfiber scaffold-based 3D in vitro human neuronal culture model of Alzheimer's disease. (2020) (11)
- Polymorphisms in candidate genes: implications for the current treatment of Parkinson’s disease (2006) (11)
- Parkinson's Disease Caregiver Strain in Singapore (2020) (11)
- LRRK2 G2019S founder haplotype in the Chinese population (2007) (11)
- The Characteristics of Patients Associated With High Caregiver Burden in Parkinson's Disease in Singapore (2019) (11)
- Subjective cognitive Complaints in early Parkinson's disease patients with normal cognition are associated with affective symptoms. (2020) (11)
- Putaminal Diffusivity Correlates With Disease Progression in Parkinson's Disease (2016) (11)
- Fully automated leg tracking of Drosophila neurodegeneration models reveals distinct conserved movement signatures (2019) (11)
- Association of LRRK2 Haplotype With Age at Onset in Parkinson Disease (2018) (11)
- Case control MR‐CISS and 3D TOF MRA imaging study of medullary compression and hypertension in hemifacial spasm (2008) (11)
- Linking LINGO1 to essential tremor (2010) (11)
- Aggregation-induced emission (AIE) nanoparticles labeled human embryonic stem cells (hESCs)-derived neurons for transplantation. (2021) (11)
- Clinicopathological correlation of psychosis and brain vascular changes in Alzheimer’s disease (2016) (11)
- A longitudinal study of non-motor symptom burden in Parkinson's disease after a transition to expert care. (2015) (11)
- Plasma ubiquitin C-terminal hydrolase L1 levels reflect disease stage and motor severity in Parkinson’s disease (2020) (10)
- Patterns of linkage disequilibrium at PARK16 may explain variances in genetic association studies (2015) (10)
- Vascular parkinsonism in moyamoya: Microvascular biopsy and imaging correlates (2003) (10)
- DTI Profiles for Rapid Description of Cohorts at the Clinical-Research Interface (2019) (10)
- Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene. (2017) (10)
- Facial diplegia: cranial variant of Guillain-Barré syndrome? (1999) (10)
- Isolated facial myorhythmia (2007) (10)
- Differentiating Non-Motor Symptoms in Parkinson's Disease from Controls and Hemifacial Spasm (2013) (10)
- The impact of levodopa therapy-induced complications on quality of life in Parkinson’s disease patients in Singapore (2019) (10)
- Nonsynonymous variants in MC1R are rare in Chinese Parkinson disease cases (2015) (9)
- B vitamins and cognition in subjects with small vessel disease: A Substudy of VITATOPS, a randomized, placebo-controlled trial (2017) (9)
- Dopamine agonists and their role in Parkinson’s disease treatment (2003) (9)
- Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study (2017) (9)
- MTHFR C677T variant reduces risk of sporadic Parkinson's disease in ethnic Chinese (2014) (9)
- Linking a genome‐wide association study signal to a LRRK2 coding variant in Parkinson's disease (2016) (9)
- Screening for TMEM230 mutations in young-onset Parkinson's disease (2017) (9)
- Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T. (2017) (9)
- Genetic analysis of “leucine‐rich repeat (LRR) and immunoglobulin (Ig) domain‐containing, Nogo receptor‐interacting protein‐1 (LINGO1)” in two independent Chinese parkinson's disease populations (2011) (9)
- GSK3β reduces risk of sporadic Parkinson's disease in ethnic Chinese (2012) (8)
- Reversible Choreoathetosis in Primary Cerebral Lymphoma: Clinicoradiologic Correlation (2003) (8)
- Trans‐Ethnic Fine‐Mapping of the Major Histocompatibility Complex Region Linked to Parkinson's Disease (2021) (8)
- Parkinson’s disease following COVID-19: causal link or chance occurrence? (2020) (8)
- FUS-linked essential tremor associated with motor dysfunction in Drosophila (2016) (8)
- Stage-Specific Relationship between Frailty and Cognitive Impairment in a Specialist Memory Clinic Setting. (2014) (8)
- Vascular tortuosity in relationship with hypertension and posterior fossa volume in hemifacial spasm (2016) (8)
- Genetic testing of LRRK2 in Parkinson's disease: is there a clinical role? (2014) (8)
- Radiological placement of 211 central venous catheters: outcome and complications. (1999) (8)
- Periventricular White Matter Abnormalities on Diffusion Tensor Imaging of Postural Instability Gait Disorder Parkinsonism (2019) (8)
- Analysis of-Synuclein Gene Promoter Variability and Parkinson Disease (2006) (8)
- Two heterozygous progranulin mutations in progressive supranuclear palsy. (2021) (8)
- Patient-Centric Care for Parkinson's Disease: From Hospital to the Community (2020) (8)
- Holding on to statins in Parkinson disease (2013) (8)
- Genetic analysis of CHCHD2 gene in Chinese Parkinson's disease (2016) (8)
- Neurodegeneration: Etiologies and New Therapies (2015) (8)
- Microcarrier-Expanded Neural Progenitor Cells Can Survive, Differentiate, and Innervate Host Neurons Better When Transplanted as Aggregates (2016) (8)
- Clinical evidence linking coffee and tea intake with Parkinson’s disease (2011) (8)
- LRRK2 A419V Is Not Associated with Parkinson's Disease in Different Chinese Populations (2012) (8)
- Pathogenicity of LRRK2 P755L variant in Parkinson's disease (2008) (8)
- A Trial of Focused Ultrasound Thalamotomy for Essential Tremor. (2016) (8)
- Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population (2015) (7)
- Altered striatal dopamine levels in Parkinson’s disease VPS35 D620N mutant transgenic aged mice (2020) (7)
- Coffee and Parkinson's Disease (2012) (7)
- Genes and Nonmotor Symptoms in Parkinson's Disease. (2017) (7)
- Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experience (2020) (7)
- Olfactory dysfunction and COVID-19 (2020) (7)
- Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene. (2017) (7)
- Camptocormia in Parkinson’s disease: Dystonia or myopathy? (2012) (7)
- Coffee and Parkinson's Disease (2012) (7)
- LRRK2 N551K and R1398H variants are protective in Malays and Chinese in Malaysia: A case–control association study for Parkinson's disease (2019) (7)
- Functional parkin promoter polymorphism in Parkinson's disease: New data and meta-analysis (2011) (7)
- Impaired motor imagery in patients with essential tremor: A case control study (2007) (7)
- Evaluation of novel Parkinson's disease candidate genes in the Chinese population (2019) (7)
- Evaluating LRRK2 Genetic Variants with Unclear Pathogenicity (2015) (7)
- Susceptibility-weighted MRI of extrapyramidal brain structures in Parkinsonian disorders (2016) (7)
- Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease (2020) (7)
- Sleep Problems in Parkinson's Disease (2015) (6)
- COVID-19 vaccination and cultural tightness (2021) (6)
- Age Cut Off for Early Onset Parkinson Disease: Recommendations from the EOPD Disease Task Force (2022) (6)
- Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease. (2017) (6)
- Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications (2020) (6)
- Case-control analysis of LRRK2 protective variants in Essential Tremor (2018) (6)
- Age Cut Off for Early Onset Parkinson Disease: Recommendations from the EOPD Disease Task Force (2022) (6)
- Familial Parkinson's Disease/Parkinsonism (2015) (6)
- Growth rate of patient-derived lymphoblastoid cells with LRRK2 mutations. (2008) (6)
- Parkinson’s disease GWAS-linked Park16 carriers show greater motor progression (2019) (6)
- Health-Related Quality of Life of Caregivers of People with Parkinson's Disease in Singapore (2010) (6)
- ITPKB and ZNF184 are associated with Parkinson's disease risk in East Asians (2020) (6)
- Bilateral trapezius hypertrophy with dystonia and atrophy (2007) (6)
- NOTCH2NLC-linked neuronal intranuclear inclusion body disease and fragile X-associated tremor/ataxia syndrome. (2020) (6)
- Dissociative semantic breakdown in Alzheimer's disease: Evidence from multiple category fluency test (2013) (6)
- PromISR-6, a Guanabenz Analogue, Improves Cellular Survival in an Experimental Model of Huntington's Disease. (2019) (6)
- Paroxysmal Movement Disorders: Recent Advances (2019) (6)
- Large 3‐Mb deletions at 22q11.2 locus in Parkinson's disease and schizophrenia (2016) (6)
- Safeguarding Non-COVID-19 Research: Looking Up from Ground Zero (2020) (5)
- Spectrum of anxiety symptoms in hyperkinesias (2008) (5)
- Mild Parkinsonian Signs in a Community Ambulant Population. (2020) (5)
- Rare and common LRRK2 exonic variants in Parkinson's disease (2011) (5)
- Increased Activation of Default Mode Network in Early Parkinson’s With Excessive Daytime Sleepiness (2019) (5)
- Neurochemistry changes associated with mutations in familial Parkinson's disease. (2010) (5)
- Diffusion weighted MR imaging in acute stroke: the SGH experience. (2002) (5)
- Peripheral edema and dopamine agonists in Parkinson disease. (2007) (5)
- Primary vs postparalytic hemifacial spasm. (2006) (4)
- Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP (2021) (4)
- Clinical correlates of white matter lesions in Parkinson's disease using automated multi-modal segmentation measures (2021) (4)
- Genome-wide association studies: promises and pitfalls. (2010) (4)
- Chromosomal deletion at 22q11.2 and Parkinson's disease (2016) (4)
- Remote Prescription During Pandemic: Challenges and Solutions (2021) (4)
- Trigeminal neuralgia: should MRI be done routinely? (1998) (4)
- Case-control study of hypertension and Parkinson’s disease (2021) (4)
- Re-defining neurological syndromes: the genotype meets the phenotype. (2006) (4)
- Genetic marker linking inflammation with sporadic Parkinson's disease. (2011) (4)
- Association analysis of PSAP variants in Parkinson's disease patients. (2020) (4)
- Case-control analysis of leucine-rich repeat kinase 2 protective variants in Alzheimer's disease (2017) (4)
- Physical Activity Improves Anxiety and Apathy in Early Parkinson's Disease: A Longitudinal Follow-Up Study (2021) (4)
- Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions (2022) (4)
- No Association of Four Candidate Genetic Variants in MnSOD and SYNIII with Parkinson's Disease in Two Chinese Populations (2014) (4)
- Applying Artificial Intelligence to Multi‐Omic Data: New Functional Variants in Parkinson's Disease (2021) (4)
- Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease (2020) (4)
- Neurovascular compression syndromes and hypertension: clinical relevance (2007) (4)
- American Society for Stereotactic and Functional Neurosurgery Bestows Distinguished Service Award on Dr. med. h.c. mult. Thomas Karger and Prof. Dr. Phil Gildenberg (2003) (4)
- Linking statins and lipids in Parkinson's disease (2017) (4)
- The association between Parkinson’s disease and Sexual dysfunction: Clinical correlation and therapeutic implications (2022) (4)
- No association of DNM3 with age of onset in Asian Parkinson's disease (2018) (3)
- Characteristics of Chinese-English bilingual dyslexia in right occipito-temporal lesion (2017) (3)
- Multiple System Atrophy (MSA) and smoking: a meta-analysis and mechanistic insights (2020) (3)
- Association of familial ataxia and restless legs syndrome. (2007) (3)
- Vitamin D Deficiency and its Relation to Underlying Stroke Etiology in Ethnic Asian Ischemic Stroke Patients (2013) (3)
- Leucine-Rich Repeat Kinase 2-Linked Parkinson’s Disease: Clinical and Molecular Findings (2010) (3)
- Identification of Targets from LRRK2 Rescue Phenotypes (2021) (3)
- G2019S LRRK2 Increases Stress Susceptibility Through Inhibition of DAF-16 Nuclear Translocation in a 14-3-3 Associated-Manner in Caenorhabditis elegans (2018) (3)
- Digit span: a comparison of Chinese versus alphabetic language speakers in dysexecutive dementia patients (2013) (3)
- Transient Paroxysmal Dyskinesia Associated with Focal Basal Ganglia Lesions (2003) (3)
- Risk factors for respiratory failure of motor neuron disease in a multiracial Asian population (2017) (3)
- Stroke-related restless legs syndrome: epidemiology, clinical characteristics, and pathophysiology. (2022) (3)
- Test–retest repeatability of assessing environmental and lifestyle factors in Parkinson's disease (2008) (3)
- High Diagnostic Utility Incorporating a Targeted Neurodegeneration Gene Panel With MRI Brain Diagnostic Algorithms in Patients With Young-Onset Cognitive Impairment With Leukodystrophy (2021) (3)
- Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson’s disease (2020) (3)
- Stability of MDS-UPDRS Motor Subtypes Over Three Years in Early Parkinson's Disease (2021) (3)
- Positive predictive value of different methods for identifying Parkinson's disease cases in an epidemiological study. (2018) (3)
- The splenial angle: a novel radiological index for idiopathic normal pressure hydrocephalus (2021) (3)
- Chetomin rescues pathogenic phenotype of LRRK2 mutation in drosophila (2020) (3)
- Polygenic Risk Scores in a Prospective Parkinson's Disease Cohort (2021) (3)
- Nonmotor symptoms in sporadic versus familial forms of Parkinson's disease. (2015) (3)
- Adverse Effects were not the Main Causes for Rotigotine PatchWithdrawal in Parkinsons Disease (2015) (2)
- Increased expression of pathological markers in Parkinson’s disease dementia post-mortem brains compared to dementia with Lewy bodies (2022) (2)
- Stem Cell Replacement Therapies in Parkinson's Disease. (2019) (2)
- Chapter 2 Causes of Parkinson's disease: genetics, environment and pathogenesis (2010) (2)
- Correction: Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria (2018) (2)
- High Outpatient Attendance During COVID‐19 Lockdown When Patients Were Given the Option to Return (2020) (2)
- Genetic analysis of SCA 27 in ataxia and childhood onset postural tremor (2007) (2)
- Unexpected cause of anxiety and Parkinsonism. (2007) (2)
- Evaluation of trigeminal nerve tractography using two-fold-accelerated simultaneous multi-slice readout-segmented echo planar diffusion tensor imaging (2020) (2)
- SNCA Rep1 microsatellite length influences non-motor symptoms in early Parkinson’s disease (2020) (2)
- Neurological research & training after the easing of lockdown in countries impacted by COVID-19 (2020) (2)
- Genetics: Utility of next-generation sequencing in ataxias (2013) (1)
- Lewy Body in Parkinson's Disease: Causes or Scars of Neurodegeneration? (2014) (1)
- Biomarker characterization of clinical subtypes of Parkinson Disease (2022) (1)
- Dopamine (DA) toxicity in pathogenesis and therapy of Parkinson's disease (PD). (2017) (1)
- Parkinson’s Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1 (2022) (1)
- Restless Legs Syndrome: Diagnostic Criteria and Differential Diagnosis (2016) (1)
- Association between plasma neurofilament light chain levels and cognition in early Parkinson's disease (2020) (1)
- A young man with parkinsonism. (2002) (1)
- Neuropathophysiology cross-talk between Alzheimer′s and Parkinson′s disease (2018) (1)
- Physical activity and its impact on non-motor aspects of Parkinson’s disease - the Early Parkinson’s Disease Longitudinal Singapore (PALS) study (2018) (1)
- B-vitamin supplementation on mitigating post-stroke cognition and neuropsychiatric sequelae: A randomized controlled trial (2022) (1)
- Sub-clinical hypothyroidism and reversible choreoathetosis (2011) (1)
- Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort (2023) (1)
- Chest CT in asymptomatic COVID-19: benefits and concerns. (2020) (1)
- Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence (2012) (1)
- Persistent hand spasm: Movement disorder or seizure? (2007) (1)
- Impact of Covid-19 on research and training in Parkinson's disease (2022) (1)
- Appropriateness of MRI brain orders: Application of American and British guidelines (2020) (1)
- Movement disorders in 2020: clinical trials, genetic discoveries, and COVID-19 (2020) (1)
- Targeting the inflammasome in Parkinson’s disease (2022) (1)
- Neurodegeneration: Etiologies and New Therapies 2016 (2016) (1)
- Meta-analysis of the association between SORL1 variants and Alzheimer's disease (2010) (1)
- Potential Pathophysiological Crosstalk between Parkin andFBXO7 Signalling Pathways (2016) (1)
- Prognostic factors of key outcomes for motor neuron disease in a multiracial Asian population (2019) (1)
- Movement Disorders in Neurologic and Systemic Disease: The borderland between epilepsy and movement disorders (2014) (1)
- Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease (2022) (1)
- Imaging in Hemifacial Spasm and Hypertension (2007) (1)
- Association study of MCCC1/LAMP3 and DGKQ variants with Parkinson’s disease in patients of Malay ancestry (2021) (1)
- Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals. (2023) (0)
- Neuropsychiatric Genetics PARK 16 Is Associated With PD in the Malaysian Population Aroma (2016) (0)
- Sleep Problems in Parkinson's Disease The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2015) (0)
- Primary vs postparalytic hemifacial spasin. Authors' reply (2006) (0)
- A Young Man with Parkinsonism (2002) (0)
- 3.058 ANALYSIS OF LRRK2 VARIANT IN ESSENTIAL TREMOR (2012) (0)
- Neurology in the European Journal of Neurology (2010) (0)
- Parkinson's disease prediction using diffusion-based atlas approach (2010) (0)
- CLINICAL CHARACTERISTICS OF PATHOLOGICALLY CONFIRMED EARLY ONSET DEMENTIA WITH LEWY BODIES (2019) (0)
- Automated leg tracking reveals distinct conserved gait and tremor signatures in Drosophila models of Parkinson’s Disease and Spinocerebellar ataxia 3 (2018) (0)
- Expanding the DARS phenotype: Late-adult onset myelopathy and leukoencephalopathy (2023) (0)
- Caffeine intake and genetic susceptibility to Parkinson's disease (2016) (0)
- Plasma Neurofilament Light Concentration Is Associated with Diffusion-Tensor MRI-Based Measures of Neurodegeneration in Early Parkinson's Disease. (2022) (0)
- Isolated Cervical Dystonia: Diagnosis and Classification. (2023) (0)
- New insights from a multi-ethnic Asian progressive supranuclear palsy cohort. (2023) (0)
- The impact of levodopa therapy-induced complications on quality of life in Parkinson’s disease patients in Singapore (2019) (0)
- O2-07-04 COPY NUMBER POLYMORPHISM AT CHROMOSOME 19 LOCUS ASSOCIATED WITH LATE-ONSET ALZHEIMER’S DISEASE (2010) (0)
- Poor sleep quality is associated with fatigue and depression in early Parkinson's disease: A longitudinal study in the PALS cohort (2022) (0)
- High caffeine consumption show greater motor progression: a longitudinal study over 9 years (2020) (0)
- Clinical Outcomes After Ventriculo-Peritoneal Shunting in Patients With Classic vs. Complex NPH (2022) (0)
- Case-control analysis of LRRK2 protective variants in Essential Tremor (2018) (0)
- REM sleep behavior disorder and motor dysfunction in Parkinson's disease e A longitudinal study (2013) (0)
- LRRK2 variant is associated with lower risk of essential tremor (2018) (0)
- Plasma Vitamin D Levels are Lower among Ethnic Indians in Matched Pairs of Male Acute Ischaemic Stroke Patients of Indian and Chinese Ethnicity (2013) (0)
- Abstract T P147: Vitamin D Deficiency is Associated With Stroke in ethnic Chinese but Not South Asians in a Case-Control Study (2014) (0)
- CNS Presentation with Diffuse Burkitt's Lymphoma in HIV Patient (2015) (0)
- Association Analysis of COQ2 Variant in Dementia and Essential Tremor (2015) (0)
- Author response. (2014) (0)
- Multi-Modal Analysis of Gene Expression from Postmortem Brains and Blood Identifies Synaptic Vesicle Trafficking Genes to Be Associated with Parkinson's Disease (2020) (0)
- Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy (2023) (0)
- Short communication Persistent hand spasm: Movement disorder or seizure? (2007) (0)
- P3.041 LINGO1 variant increases risk of familial essential tremor (2009) (0)
- Genetic Studies of Parkinson's and Alzheimer's Disease in Latinos/Hispanics: New Insights and Challenges (2021) (0)
- microRNA-150-5p: A Novel Blood-Based Biomarker for Alzheimer’s Dementia with Good Correlation to Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral Atrophy (2021) (0)
- P3.040 Non synonymous GIGYF2 variants in Parkinson's disease (2009) (0)
- Serum peroxiredoxin 3 is reduced in genetic carriers of Parkinson’s disease (2022) (0)
- Association Between Parkinson’s Disease and Coronary Artery Disease: A Systematic Review and Meta-Analysis (2022) (0)
- Potential Implications of Mitochondrial Unfolded Protein Response in the Pathogenesis and Therapy of Dopaminergic Neuron Degeneration in Parkinson ’ s Disease (2017) (0)
- Sleep and mood predict quality of life change in Parkinson's disease: a longitudinal study (2016) (0)
- 20 Clinical characteristics of pathological confirmed early onset dementia with lewy bodies (2019) (0)
- Biomarker characterization of clinical subtypes of Parkinson Disease (2022) (0)
- 3.042 CAFFEINE-MEDIATED RISK OF PARKINSON'S DISEASE IS GREATER IN SLOW NAT2 GENOTYPE CARRIERS: CLINICAL, GENETIC AND MOLECULAR STUDY (2012) (0)
- Negative results Case-control analysis of leucine-rich repeat kinase 2 protective variants in Alzheimer ’ s disease (2018) (0)
- “Hot cross bun” is a potential imaging marker for the severity of cerebellar ataxia in MSA-C (2021) (0)
- Exploring the relationship between panic disorder and Parkinson's disease. (2007) (0)
- Evaluation of the relationship between cigarette smoking with risk of essential tremor in Singapore population (2018) (0)
- LRRK2 mutations are not frequent in Swiss patients with Parkinson's disease (2008) (0)
- Author response: MiRNA-128 regulates the proliferation and neurogenesis of neural precursors by targeting PCM1 in the developing cortex (2015) (0)
- Predicting Atrial Fibrillation after Ischemic Stroke: Clinical, Genetics, and Electrocardiogram Modelling (2022) (0)
- 2.010 CASE CONTROL DIFFUSION TENSOR IMAGING TRACTOGRAPHY STUDIES IN POSTURAL INSTABILITY GAIT DISORDER PARKINSONISM (2012) (0)
- Interaction between a GWAS-linked genetic variant and caffeine intake in Parkinson's disease (2016) (0)
- Towards better cellular replacement therapies in Parkinson disease (2018) (0)
- Sniffing for Parkinson's disease. (2023) (0)
- PINK1- and DJ-1-Linked Parkinsonism (2012) (0)
- Microstructure of Brain Nuclei in Early Parkinson’s Disease: Longitudinal Diffusion Kurtosis Imaging (2023) (0)
- P2.078 Usage and cost of complementary therapies in hemifacial spasm (2009) (0)
- 2.007 MR VOLUMETRIC ANALYSIS OF THE CORPUS CALLOSUM IN PATIENTS WITH PARKINSONISM (2012) (0)
- Combination therapy using GDNF and cell transplant in Parkinson’s disease (2022) (0)
- Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity? (2017) (0)
- An emerging new entity: IgG4 related disease (2016) (0)
- Identifying genes in Parkinson disease: state of the art (2018) (0)
- Antioxidant kinase inhibitors for LRRK2 Parkinson's disease (2016) (0)
- A case os senile-onset progressive hemiballism and cognitive decline with diffuse brain iron accumulations: Expert commentary. (2022) (0)
- A Proteome-Wide Effect of PHF8 Knockdown on Cortical Neurons Shows Downregulation of Parkinson’s Disease-Associated Protein Alpha-Synuclein and Its Interactors (2023) (0)
- Corrigendum: Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease (2020) (0)
- Next-generation sequencing diagnostics for neurological diseases/disorders: from a clinical perspective (2013) (0)
- The lived experiences of community dwelling adults with Parkinson's disease towards exercise and participation in a rehabilitation trial (2015) (0)
- Evidence of Added Value of Chest CT in Coronavirus Disease (COVID-19) Pneumonia With Initial Negative RT-PCR Results. (2020) (0)
- Editorial: The Role of Neurovascular Unit in Neurodegeneration (2022) (0)
- Interaction between caffeine intake and N-acetyltransferase 2 genotype in Parkinson's disease (2016) (0)
- Comparing COVID-19-linked neurological complications with other viral infections (2020) (0)
- Author response for "Phenotypic bases of NOTCH2NLC GGC expansion positive Neuronal Intranuclear Inclusion Disease ( NIID ) in a South East Asian cohort" (2020) (0)
- Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson’s disease (2017) (0)
- Fist-Edge-Palm (FEP) test has a high sensitivity in differentiating dementia from normal cognition in Parkinson's disease (2021) (0)
- Identifying clinical features and blood biomarkers associated with mild cognitive impairment in Parkinson disease using machine learning (2023) (0)
- Corrigendum: Increased Activation of Default Mode Network in Early Parkinson's With Excessive Daytime Sleepiness (2020) (0)
- Parkinson ’ s Disease Sleep Problems in Parkinson ’ s Disease (2015) (0)
- Questions on NOTCH2NLC Repeat Expansions in Parkinson Disease-Reply. (2021) (0)
- Thalamic pathways mediating motor and non-motor symptoms in a Parkinson’s disease model (2022) (0)
- Increased expression of pathological markers in Parkinson’s disease dementia post-mortem brains compared to dementia with Lewy bodies (2022) (0)
- TAN, Eng-King: Singapore/Singapore (2019) (0)
- Longitudinal Study of SNCA Rep1 Polymorphism on Executive Function in Early Parkinson's Disease. (2022) (0)
- Putaminal diffusivity changes correlates with motor progression in Parkinson's disease on 6-year follow-up (2016) (0)
- Investigation of LRRK2 variant and essential tremor (2018) (0)
- 3.011 GENETIC VARIATION OF BDNF IN PARKINSON'S DISEASE (2012) (0)
- Case-control study of hypertension and Parkinson’s disease (2021) (0)
- Epstein-Barr Virus Induced Dilated Cardiomyopathy (2013) (0)
- Patient-related factors’ impact on caregiver burden in Parkinson’s disease in Singapore (2018) (0)
- Myelin water imaging: Potential white matter biomarker in Parkinson's Disease (2020) (0)
- Considerations of Long-term Pain Evaluation Post-Deep Brain Stimulation Surgery. (2015) (0)
- Association study of p53 codon 72 polymorphism in Parkinson's disease (2014) (0)
- Alpha-synuclein REP 1 variants and survival in Parkinson ’ s disease (2014) (0)
- PARK 16 as a susceptibility locus Analysis of GWAS-linked loci in Parkinson disease reaffirms (2010) (0)
- Plasma Coenzyme Q10 Levels and Multiple System Atrophy. (2016) (0)
- Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson’s disease (2020) (0)
- Parkinson’s disease following COVID-19: causal link or chance occurrence? (2020) (0)
- P3.090 Heterozygous mutations in PINK1 kinase domain exert a gene dosage effect (2009) (0)
- Leucine-Rich Repeat Kinase 2-Linked Parkinson's Disease: Clinical and Molecular Findings REVIEW ARTICLE (2010) (0)
- Abstract WMP53: Vitamin D Levels Are Lower In Acute Ischemic Stroke Patients Compared To Matched Controls (2013) (0)
- Genetics of restless legs syndrome: evidence for a hereditary disorder (2007) (0)
This paper list is powered by the following services:
